Caylee Dawn Jarrett, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1300 N Market St, Sparta, IL 62286 Phone: 618-443-4138 Fax: 618-443-3327 |
Danielle Renee Preuss, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 207 S Burns Ave, Sparta, IL 62286 Phone: 618-443-2290 |
Rikki Schaefer, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 205 South Burns Ave, Sparta, IL 62286 Phone: 618-443-4112 Fax: 618-443-1357 |
Danielle Scott, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1300 N Market St, Sparta, IL 62286 Phone: 618-443-4138 Fax: 618-443-3685 |
Dana Lakatos, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1300 N Market St, Sparta, IL 62286 Phone: 618-443-1337 Fax: 618-443-1383 |
News Archive
CardioGenics Holdings Inc., a developer of technology and products targeting the immunoassay segment of the IVD testing market, reports that Merck Chimie S.A.S. ("Merck Chimie") is progressing to the next phase of the commercialization of CardioGenics' proprietary silver coated paramagnetic Beads ("Beads").
Intellect Neurosciences, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent related to the Company's humanized monoclonal antibody, IN-N01, being developed as a disease-modifying treatment for Alzheimer's disease and other related indications.
Deep brain stimulation (DBS) improves many of the motor symptoms of Parkinson's disease (PD) and is a life-alerting surgery for many patients. Penn Medicine's Gordon Baltuch, MD, a professor of Neurosurgery and director of the Penn Center for Functional and Restorative Neurosurgery, is one of the most prolific DBS surgeons in the world, having recently performed his 1,000th procedure, marking an important milestone for Baltuch and Penn Medicine.
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests, researchers from the University of Illinois at Chicago have found that the disease affects other organs in 40 percent of patients with cardiac sarcoidosis.
› Verified 5 days ago